Results 201 to 210 of about 9,273,371 (361)

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study. [PDF]

Menopause
James TT, Dowling NM, Ferrer Simó C, Salazar H, Van Hulle CA, Ennis G, Johnson AL, Wyman MF, McLester-Davis LWY, Gooding DC, Fischer B, Bouges S, Umucu E, Kara F, Kling JM, Manson JE, Brinton EA, Cedars MI, Lobo RA, Neal-Perry G, Santoro NF, Naftolin F, Harman SM, Pal L, Miller VM, Kantarci K, Gleason CE.   +26 more
europepmc   +1 more source

Astrocyte scar formation aids central nervous system axon regeneration

Nature, 2016
Mark A. Anderson, J. Burda, Yilong Ren, Y. Ao, T.M. O’Shea, R. Kawaguchi, G. Coppola, B. Khakh, T. Deming, M. Sofroniew   +9 more
semanticscholar   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Response to letter regarding 'bidirectional association of daily steps with sarcopenia: a longitudinal study'. [PDF]

Ann Med
Wang Y, Wu Z, Zhang Y, Wei J, Lei G, Zeng C.   +5 more
europepmc   +1 more source

A Central Array Method to Locate Chips in AOI Systems in Semiconductor Manufacturing [PDF]

Huichu Fu, Yiming Lai, Chunrong Pan, Siwei Zhang, Liping Bai, Jie Li   +5 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Central American Mangrove Blue Carbon: Distribution, Dynamics and Future Directions. [PDF]

Wetlands (Wilmington)
Girkin NT, Canty SWJ, Rovai AS, Morrissette HK, Collin R, Shukla Y, Romero-González TE, Quirós J, Pineda J, Wong JR, Cifuentes-Jara M.   +10 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy. [PDF]

Toxins (Basel)
Chaudhry BA, Robinson CL, Caronna E, Dodd-Glover F, Virk AS, Prieto Peres MF, O'Brien HL, Romero-Reyes M, Ashina S.   +8 more
europepmc   +1 more source